Brought to you by:
Study finds adverse outcomes after decreased use of paclitaxel-coated devices
A recent analysis of over 270,000 Medicare fee-for-service beneficiaries has found an increase in adverse outcomes and death after a US Food and Drug Administration (FDA) warning led to decreased use of paclitaxel-coated devices for peripheral revascularisation procedures. Writing in…
SVS member picks up prestigious American Heart Association accolade for scientific work
A prominent surgeon-scientist and Society for Vascular Surgery (SVS) member is the 2024 recipient of the American Heart Association (AHA) Joseph A. Vita Award, which recognizes published work that has had a transformative impact on basic, translational or clinical cardiovascular…
The good, the bad and the bloody: Reflections on the road to residency
As my third year of residency comes to a close, that little thing called The Match feels like a distant fever dream. The memories of Electronic Residency Application Service (ERAS) application anxiety now tinted with the rose-colored glasses of a…
APDVS says goodbye to two long-term leaders during spring meeting
The 2024 Association of Program Directors in Vascular Surgery (APDVS) convened in Chicago April 5–6 for their annual spring meeting, which held the record for the highest-attended in APDVS history. APDVS 2024 covered important topics for vascular surgery program directors,…
More than half of medical students altered Match ranking order after post-virtual interview site visits, APDVS survey finds
Amid the build-up to residency Match Day 2024, the Association of Program Directors in Vascular Surgery (APDVS) has delivered data from a VISIT (Vascular In-Person for Students in the Match Trial) pilot study that took place last year showing some…
EU ministers approve changes to MDR transition timetable
The European Union’s Council of Ministers has today adopted a resolution to extend the deadline for the certification of medical devices under the Medical Devices Regulation (MDR). Producers of medical devices will have until Dec. 31, 2027, for higher risk…
‘SVS Presents’ provides enhanced learning opportunities
The Society for Vascular Surgery (SVS) will debut “SVS Presents” April 12, a monthly webinar series that provides an evening of educational programming for members. “Presents” is in response to a key finding from the 2021 Educational Needs Assessment and…
Has the risk in the value-based payment model been sold as another ‘shiny new object’?
Value-based payments (VBP), or “volume to value,” was the new buzz word over a decade ago, promising yet another chimera in ways to reimburse physicians and hospitals based upon “value,” instead of fee-for-service (FFS). VBP models link payment or compensation to…
Envision, private equity and patient care: Substituted values 2.0
He was only 41, already burdened with multiple health problems. Diabetes, hypertension and renal failure had put him on dialysis, caused the amputation of his left leg, and now left him with poor circulation in his right leg. Signs of…
VSGBI spotlights data-driven financial incentives for PAD revascularization
The President’s Symposium at the Vascular Society of Great Britain and Ireland (VSGBI) annual scientific meeting (Nov. 23–25) in Brighton, England, saw Rob Sayers, MD, from the University of Leicester, presenting, “CLTI CQUIN [Commissioning for Quality and Innovation] has raised…